Wan Han-Xing, Hu Jian-Hong, Xie Rei, Yang Shi-Ming, Dong Hui
Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, P.R. China.
Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Diego, California, USA.
Oncotarget. 2016 May 10;7(19):28736-47. doi: 10.18632/oncotarget.7518.
Purinergic signaling is important for many biological processes in humans. Purinoceptors P2Y are widely distributed in human digestive system and different subtypes of P2Y receptors mediate different physiological functions from metabolism, proliferation, differentiation to apoptosis etc. The P2Y receptors are essential in many gastrointestinal functions and also involve in the occurrence of some digestive diseases. Since different subtypes of P2Y receptors are present on the same cell of digestive organs, varying subtypes of P2Y receptors may have opposite or synergetic functions on the same cell. Recently, growing lines of evidence strongly suggest the involvement of P2Y receptors in the pathogenesis of several digestive diseases. In this review, we will focus on their important roles in the development of digestive inflammation and cancer. We anticipate that as the special subtypes of P2Y receptors are studied in depth, specific modulators for them will have good potentials to become promising new drugs to treat human digestive diseases in the near future.
嘌呤能信号传导对人类的许多生物学过程都很重要。嘌呤受体P2Y广泛分布于人类消化系统,不同亚型的P2Y受体介导从代谢、增殖、分化到凋亡等不同的生理功能。P2Y受体在许多胃肠功能中至关重要,也参与一些消化系统疾病的发生。由于不同亚型的P2Y受体存在于消化器官的同一细胞上,不同亚型的P2Y受体可能在同一细胞上具有相反或协同的功能。最近,越来越多的证据强烈表明P2Y受体参与了几种消化系统疾病的发病机制。在这篇综述中,我们将重点关注它们在消化炎症和癌症发展中的重要作用。我们预计,随着对P2Y受体特殊亚型的深入研究,针对它们的特异性调节剂在不久的将来很有可能成为治疗人类消化系统疾病的有前景的新药。